$20M revenue by 2 July 2020....hopefully the share holders get to vote if they can extend it if that milestone isn't reached and BL doesn't have significant shares to vote, I am guessing a majority of us will vote NO given they caused the 1st clinical trial stuff up in the US (blessing in disguise as I was able to average down big time and they also miss their revenue target).
RAP Price at posting:
39.5¢ Sentiment: Buy Disclosure: Held
